Document is current
Any future updates will be listed below
-
Authors
Gilling, Peter
Chin, Peter
Anderson, Paul https://orcid.org/0000-0003-3348-9597
Zorn, Kevin https://orcid.org/0000-0003-3651-6669
Matsumoto, Edward D. https://orcid.org/0009-0004-3120-3406
Lynch, William
Chan, Lewis
Woo, Henry
Pérez Becerra, Rodrigo
Brennan, Janelle
Elterman, Dean https://orcid.org/0000-0003-1507-7783
-
Funding
Funding for this research was provided by:
Zenflow, Inc.
- License Information
-
More Information
Article History
Received: 22 December 2025
Revised: 24 April 2026
Accepted: 21 May 2026
First Online: 9 June 2026
Competing interests
: PG, PC, PA, KZ, EDM, WL, LC, HW, RPB, JB, and DE served as principal investigators (PI) on this clinical trial. PG is a study investigator for Procept Biorobotics, Rivermark and Resurge. PC is a consultant and proctor for Teleflex. KZ is a consultant/advisor for Procept, BSCI, Laborie, and Zenflow. WL is a consultant for Rigicon, Boston Scientific, Medtronic, and Inopase. DE is a consultant/advisor for Astellas, Boston Scientific, Laborie, Medtronic, Pierre Fabre, Procept BioRobotics, Prodeon, Proverum, Butterfly, and Zenflow.
